On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Protein-glycan interactions
- Reasons for new methodology
- Chemokine CCL5 interactions with GAGs
- Crystal structure of a CCL5 dimer
- NMR provides ligand binding information
- STD-NOESY of 444 complex
- Building models with a ligand
- NMR works well for studies of smaller systems
- Residual dipolar coupling (RDC)
- WT CCL5 at low pH
- RDC data for E66S and WT CCL5
- Multiple models for the tetramer structure
- SAXS data yield additional shape restrictions
- Fixing dimer orientations
- Cross-saturation confirms interface residues
- MS hydroxyl radical footprinting
- Radical footprinting & NMR cross-saturation
- Tetramer model extends to higher oligomers
- Modeling in longer GAG oligomers
- Glycans on a glycoprotein
- Why do we care about IgG glycosylation?
- How do glycans modulate receptor interactions?
- Glycans on native IgG-Fc are very heterogeneous
- Investigating differential branch accessibility
- Preparing IgG with homogeneous 13C glycans (1)
- Production of 13C labeled IgG-Fc fragment
- 1-3 branch is mobile and 1-6 branch is restrained
- Relaxation dispersion probes slow exchange
- Relaxation dispersion and chemical shift data
- Model for galactose terminated Fc glycans
- Locating glycans more precisely
- Predicted distances based on 1IGT structure
- Gal PREs in the Dy+++ : Z-L2LBT: Fc complex
- Sialylated glycans and rheumatoid arthritis
- Sialic acid can be produced in a labeled form
- Preparing IgG with homogeneous 13C glycans (2)
- 13C-Gal labeled Fc + & - sialic acid
- Sialic acid addition & observation of NMR spectra
- CPMG R2 relaxation can be measured
- Di-sialylation & shift to glycan-exposed state
- Summary
- Acknowledgments
Topics Covered
- NMR studies
- Protein structure
- Protein-protein Interactions
- Building models with a ligand
- Chemokine CCL5 interactions with GAGs
- STD-NOESY
- Residual dipolar coupling (RDC)
- SAXS data
- Cross-saturation
- Radical footprinting
- Glycans on a glycoprotein
- - Preparing IgG with homogeneous 13C glycans
- Relaxation dispersion
- Galactose terminated Fc glycans Locating glycans more precisely
- Sialylated glycans
- CPMG R2 relaxation
- Di-sialylation
Talk Citation
Prestegard, J. (2012, November 27). Protein-glycan interactions [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/YHGU1308.Export Citation (RIS)
Publication History
- Published on November 27, 2012
Financial Disclosures
- Prof. James Prestegard has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.